Looking for Trouble and Finding It.
作者信息
Trinidad Susan B, Fullerton Stephanie M, Burke Wylie
机构信息
a University of Washington.
出版信息
Am J Bioeth. 2015;15(7):15-7. doi: 10.1080/15265161.2015.1039731.
Abstract
摘要
相似文献
1
Looking for Trouble and Finding It.自找麻烦
Am J Bioeth. 2015;15(7):15-7. doi: 10.1080/15265161.2015.1039731.
2
Response to Open Peer Commentaries on "Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice".对关于《自找麻烦：普通人群中的预防性基因组测序及患者选择的作用》的开放同行评论的回应
Am J Bioeth. 2015;15(12):W6-9. doi: 10.1080/15265161.2015.1096069.
3
Patient Choice and Preventive Genomic Sequencing--More Trouble Upstream.患者选择与预防性基因组测序——上游的更多问题
Am J Bioeth. 2015;15(7):24-6. doi: 10.1080/15265161.2015.1039729.
4
Double Trouble: Preventive Genomic Sequencing and the Case of Minors.双重麻烦：预防性基因组测序与未成年人案例
Am J Bioeth. 2015;15(7):30-1. doi: 10.1080/15265161.2015.1039723.
5
Variants of Unknown Significance and Their Impact on Autonomy.意义未明的变异及其对自主性的影响。
Am J Bioeth. 2015;15(7):26-8. doi: 10.1080/15265161.2015.1039727.
6
Next Generation DNA Sequencing: Always Allow an Opt Out.下一代DNA测序：始终允许选择退出。
Am J Bioeth. 2015;15(7):28-30. doi: 10.1080/15265161.2015.1039726.
7
Scrutinizing the Right Not to Know.审视不知情权
Am J Bioeth. 2015;15(7):17-9. doi: 10.1080/15265161.2015.1039733.
8
Preventive Genomic Sequencing and Care of the Individual Patient.预防性基因组测序与个体患者护理
Am J Bioeth. 2015;15(7):32-3. doi: 10.1080/15265161.2015.1039725.
9
Preventive Genomic Sequencing in the General Population: Do PGS Fly?普通人群中的预防性基因组测序：PGS可行吗？
Am J Bioeth. 2015;15(7):1-2. doi: 10.1080/15265161.2015.1054160.
10
Ethics Preparedness for Public Health Emergencies: Recommendations From the Presidential Bioethics Commission.公共卫生紧急事件的伦理准备：总统生物伦理委员会的建议
Am J Bioeth. 2015;15(7):77-9. doi: 10.1080/15265161.2015.1054162.
引用本文的文献
1
The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.全基因组测序对健康成年患者的初级保健和结局的影响：一项先导随机试验。
Ann Intern Med. 2017 Jun 27;167(3):159-169. doi: 10.7326/M17-0188. Print 2017 Aug 1.
本文引用的文献
1
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.美国医学遗传学与基因组学学会政策声明：关于临床全基因组测序中次要发现的分析和报告的更新建议
Genet Med. 2015 Jan;17(1):68-9. doi: 10.1038/gim.2014.151. Epub 2014 Nov 13.
2
Genomic screening of the general adult population: key concepts for assessing net benefit with systematic evidence reviews.普通成年人群的基因组筛查：通过系统证据综述评估净效益的关键概念
Genet Med. 2015 Jun;17(6):441-3. doi: 10.1038/gim.2014.129. Epub 2014 Sep 18.
3
Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.基于人群的BRCA1和BRCA2基因筛查：2014年拉斯克奖
JAMA. 2014 Sep 17;312(11):1091-2. doi: 10.1001/jama.2014.12483.
4
Clinical interpretation and implications of whole-genome sequencing.全基因组测序的临床解读及意义。
JAMA. 2014 Mar 12;311(10):1035-45. doi: 10.1001/jama.2014.1717.
5
Recommendations for returning genomic incidental findings? We need to talk!关于如何报告基因组偶然发现的建议？我们需要谈谈！
Genet Med. 2013 Nov;15(11):854-9. doi: 10.1038/gim.2013.113. Epub 2013 Aug 1.
6
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
7
Unwanted control: how patients in the primary care setting decide about screening for prostate cancer.非意愿性控制：基层医疗环境中的患者如何决定是否进行前列腺癌筛查。
Patient Educ Couns. 2005 Jan;56(1):116-24. doi: 10.1016/j.pec.2003.12.002.
8
Uses and abuses of screening tests.筛查试验的用途与滥用
Lancet. 2002 Mar 9;359(9309):881-4. doi: 10.1016/S0140-6736(02)07948-5.
Zotero 插件